Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2020 14:09 ET | Source: BioSig Technologies, Inc.

Biotech and Investment Veteran Dennis Purcell Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.

Westport, CT, May 05, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) today appointed Mr. Dennis Purcell to the Board of Directors of its majority-owned...
May 04, 2020 14:41 ET | Source: Bragar Eagel & Squire

QUINTANA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of QES and Encourages Investors to Contact the Firm

NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
May 01, 2020 10:39 ET | Source: BioSig Technologies, Inc.

BioSig Resumes Clinical Activities with PURE EP System

Westport, CT, May 01, 2020 (GLOBE NEWSWIRE) -- Clinical support staff to return to perform elective procedures at Texas Cardiac Arrhythmia Institute as of May 4, 2020Company reconfirms its...
April 30, 2020 09:20 ET | Source: BioSig Technologies, Inc.

ViralClear Submits In Vitro Data on Merimepodib and Remdesivir Synergistic Activity Against the COVID-19 Novel Coronavirus to a Peer-Reviewed Journal

Westport, CT, April 30, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) today announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination with the...
April 30, 2020 08:30 ET | Source: National Storm Recovery Inc

National Storm Recovery, Inc. (NSRI) Announces ‘Current’ Status with OTC Markets, Provides Corporate Update

ORLANDO, Fla., April 30, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – National Storm Recovery Inc. (OTC: NSRI) (“NSRI” or the “Company”), a leading provider of environmentally beneficial solutions to...
April 28, 2020 08:00 ET | Source: Kimball International, Inc.

Kimball International, Inc. Declares Dividend

JASPER, Ind., April 28, 2020 (GLOBE NEWSWIRE) -- Kimball International, Inc. (NASDAQ: KBAL) The Board of Directors of Kimball International, Inc. declared a quarterly cash dividend of nine cents...
April 24, 2020 14:30 ET | Source: BioSig Technologies, Inc.

BioSig to Host Conference Call on Recent Developments of Subsidiary ViralClear and its Broad-Spectrum Oral Anti-Viral Candidate Merimepodib for the Treatment of COVID-19

Westport, CT, April 24, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that it will be hosting an investor briefing to provide an...
April 24, 2020 09:25 ET | Source: BioSig Technologies, Inc.

BioSig Subsidiary ViralClear Submits Investigational New Drug Application to the FDA for Phase II Clinical Trials for Merimepodib, an Orally Administered Treatment for Patients with COVID-19

Westport, CT, April 24, 2020 (GLOBE NEWSWIRE) -- In vitro studies demonstrated decrease of viral production by over 98%Upon approval, clinical trial to be conducted at Mayo Clinic under the...
April 23, 2020 09:15 ET | Source: BioSig Technologies, Inc.

ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research

Westport, CT, April 23, 2020 (GLOBE NEWSWIRE) -- Merimepodib is shown to decrease viral production of COVID-19 coronavirus more than remdesivir at clinically meaningful drug concentrations in...
April 21, 2020 14:36 ET | Source: BioSig Technologies, Inc.

Tony Zook Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.

Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) -- Former senior executive at AstraZeneca and pharmaceutical industry expert to join as Independent Director The Company is developing Vicromax(tm) – a...